MARKET

PEN

PEN

Penumbra Inc
NYSE
210.11
+0.60
+0.29%
Closed 16:05 12/01 EST
OPEN
208.85
PREV CLOSE
209.51
HIGH
213.71
LOW
207.34
VOLUME
237.65K
TURNOVER
--
52 WEEK HIGH
290.36
52 WEEK LOW
114.87
MARKET CAP
7.98B
P/E (TTM)
-258.4061
1D
5D
1M
3M
1Y
5Y
Penumbra's Return On Capital Employed Overview
Benzinga · 11/22 14:46
Penumbra Launches First Hands-Free, Full Body Virtual Reality-Based Offering for Rehabilitation, Expanding REAL® System Platform
ALAMEDA, Calif., November 15, 2022--Penumbra, Inc. today announced the first full body, non-tethered immersive healthcare offering for rehabilitation.
Business Wire · 11/15 14:00
--Truist Securities Adjusts Penumbra Price Target to $228 From $200, Maintains Buy Rating
--Truist Securities Adjusts Penumbra Price Target to $228 From $200, Maintains Buy Rating
MT Newswires · 11/14 08:20
--RBC Boosts Price Target on Penumbra to $215 From $195, Likes Positioning Into 2023; Keeps Outperform Rating
--RBC Boosts Price Target on Penumbra to $215 From $195, Likes Positioning Into 2023; Keeps Outperform Rating
MT Newswires · 11/14 07:59
Wells Fargo Maintains Overweight on Penumbra, Lowers Price Target to $225
Benzinga · 11/04 16:13
Penumbra upgraded at Citi given upcoming vascular device launches
Seekingalpha · 11/04 15:53
What 6 Analyst Ratings Have To Say About Penumbra
Benzinga · 11/04 15:34
Under Armour To Rally Over 13%? Here Are 5 Other Price Target Changes For Friday
Benzinga · 11/04 12:25
More
About PEN
Penumbra, Inc. is a global healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that focuses on medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. It has developed a product portfolio that includes seven product families within its major markets, in which its neuro products include Thrombectomy, Embolization, Access, and Neurosurgical Tools. Its vascular products include Thrombectomy and Embolization. The Company's immersive healthcare product is Immersive 3D Computer-based Technology Platform. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada, and Australia.

Webull offers kinds of Penumbra Inc stock information, including NYSE:PEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PEN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PEN stock methods without spending real money on the virtual paper trading platform.